Stay updated on ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial
Sign up to get notified when there's something new on the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page.

Latest updates to the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page
- Check3 days agoChange DetectedUpdated from v3.0.1 to v3.0.2 and removed the 'Back to Top' element. No other core content or key information appears to have changed.SummaryDifference0.1%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%
- Check18 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations related to ovarian cancer treatment, as well as the inclusion of a new study on rucaparib for relapsed ovarian cancer. Several previous entries have been removed, particularly those related to locations and cancer types.SummaryDifference8%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.6%
Stay in the know with updates to ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page.